Stephen Knight was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
Name: Stephen Knight
Organisation: F Prime Capital Partners
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Stephen Knight, LSIPR 50, LSIPR 50 2018, F Prime Capital Partners, pharmaceutical, biotechnology, CRISPR, Caribou Biosciences, Menlo Therapeutics
